Biocon Biologics expands partnership with Civica to launch Insulin Glargine in the US EP News Bureau Oct 17, 2025 Biocon Biologics and Civica collaboration aims to increase access to affordable insulin in the United States
Biocon Biologics and Viatris get EC Approval for Kixelle, biosimilar insulin Aspart EP News Bureau Feb 12, 2021 Kixelle, a fast-acting insulin analog indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1…
